Grants and Contributions:

Back to search

Title:

Reagent Procurement Optimization

Agreement Number:

1003014

Agreement Value:

$367,000.00

Agreement Date:

Jan 9, 2023 - Mar 31, 2023

Description:

BenchSci enables pre-clinical pharmaceutical research scientists to select experimental reagents and model systems based on the documented history of experiments. As history contains a very large number of documented experiments, a “search” can result in a huge number of results. Many factors play into every drug development experiment, making the selection between all options difficult. Today, BenchSci uses a simple historic popularity ranking and this project will replace this ranking with a new ranking that incorporates as many experimental design factors as possible enabled by an ML model. This should create a significantly more accurate ranking without requiring an explicit understanding of every factor in a successful selection.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Toronto, Ontario, CA M5J 2V5

Reference Number:

172-2022-2023-Q4-1003014

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

794864926

Recipient Type:

For-profit organization

Recipient's Operating Name:

BenchSci

Recipient's Legal Name:

Scinapsis Analytics Inc.

Federal Riding Name:

Spadina--Fort York

Federal Riding Number:

35101

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

54171